Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone Injection for Opioid-Induced Constipation in Advanced Cancer Patients
CTR20131172Phase 2Suspended
- Sponsor
- Chongqing Pharmaceutical (Group) Co., Ltd.
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Chongqing Pharmaceutical (Group) Co., Ltd.. Started Jul 2014; status: suspended.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on CTR20131172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131172.